These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Visceral leishmaniasis in immunocompromised: diagnostic and therapeutic approach and evaluation of the recently released IDSA guidelines. Pagliano P; Ascione T; Di Flumeri G; Boccia G; De Caro F Infez Med; 2016 Dec; 24(4):265-271. PubMed ID: 28011960 [TBL] [Abstract][Full Text] [Related]
4. [Two cases of visceral leishmaniasis from Kahramanmaraş, Turkey]. Karaoğlan İ; Ekşi F; Haydaroğlu Şahin H; Pehlivan M; Tekin Şahin S; Keçik Boşnak V; Bilici M; Namıduru M; Karslıgil T Mikrobiyol Bul; 2015 Apr; 49(2):295-8. PubMed ID: 26167831 [TBL] [Abstract][Full Text] [Related]
5. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child. Meinecke CK; Schottelius J; Oskam L; Fleischer B Pediatrics; 1999 Nov; 104(5):e65. PubMed ID: 10545591 [TBL] [Abstract][Full Text] [Related]
6. [Interpretation of laboratory data during cryptic leishmaniasis in dog]. Gravino AE Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723 [TBL] [Abstract][Full Text] [Related]
7. [Leishmania infantum/HIV co-infection: cutaneous lesions following treatment of visceral leishmaniasis]. Catorze G; Alberto J; Afonso A; Vieira R; Cortes S; Campino L Ann Dermatol Venereol; 2006 Jan; 133(1):39-42. PubMed ID: 16495850 [TBL] [Abstract][Full Text] [Related]
9. Tumor lysis-like syndrome in a child during treatment for visceral leishmaniasis. Tragiannidis A; Papageorgiou M; Stamou M; Hatzipantelis E; Papageorgiou T; Giannopoulos A; Damianidou L; Pappa A; Pappa S; Hatzistilianou M Int J Immunopathol Pharmacol; 2016 Sep; 29(3):458-60. PubMed ID: 27025597 [TBL] [Abstract][Full Text] [Related]
10. [A multifocal form of cutaneous leishmaniasis caused by Leishmania infantum in an immunocompetent child treated with a short course of liposomal amphotericin B]. Taquin H; Chiaverini C; Marty P; Lacour JP Ann Dermatol Venereol; 2016 Oct; 143(10):622-624. PubMed ID: 27292718 [TBL] [Abstract][Full Text] [Related]
11. Isolated laryngeal leishmaniasis in an immunocompetent patient: a case report. Tiseo D; Tosone G; Conte MC; Scordino F; Mansueto G; Mesolella M; Parrella G; Pennone R; Orlando R Infez Med; 2008 Dec; 16(4):233-5. PubMed ID: 19155691 [TBL] [Abstract][Full Text] [Related]
12. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs. Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751 [TBL] [Abstract][Full Text] [Related]
13. [Kala azar - Lethal course of visceral leishmaniasis. Synchronous infection with Leishmania donovani/infantum complex and Leishmania major in a patient after Mediterranean vacation]. Posch C; Walochnik J; Gschnait A; Feichtinger H; Rappersberger K Hautarzt; 2012 Dec; 63(12):947-51. PubMed ID: 23064668 [TBL] [Abstract][Full Text] [Related]
14. Manifestations of paediatric Leishmania infantum infections in Malta. Pace D; Williams TN; Grochowska A; Betts A; Attard-Montalto S; Boffa MJ; Vella C Travel Med Infect Dis; 2011 Jan; 9(1):37-46. PubMed ID: 21212024 [TBL] [Abstract][Full Text] [Related]
15. Visceral leishmaniasis in Costa Rica: first case report. Carrillo J; Chinchilla M; Valverde B; Porras O; Mora L Clin Infect Dis; 1999 Sep; 29(3):678-9. PubMed ID: 10530466 [TBL] [Abstract][Full Text] [Related]